FGF9/FGFR2 increase cell proliferation by activating ERK 1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells-Reference-Cited by-同舟云学术

FGF9/FGFR2 increase cell proliferation by activating ERK 1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells

Published:2018-10-23 Issue:11 Volume:109 Page:3503-3518
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Chang Ming‐Min¹^ORCID,Lai Meng‐Shao¹²,Hong Siou‐Ying¹,Pan Bo‐Syong³,Huang Hsin¹,Yang Shang‐Hsun²⁴,Wu Chia‐Ching¹²,Sun H. Sunny²⁵,Chuang Jih‐Ing²⁴,Wang Chia‐Yih¹²,Huang Bu‐Miin¹²⁶

Affiliation:

1. Department of Cell Biology and Anatomy College of Medicine National Cheng Kung University Tainan Taiwan

2. Department of Basic Medicine College of Medicine National Cheng Kung University Tainan Taiwan

3. Department of Cancer Biology Wake Forest University School of Medicine Winston Salem NC USA

4. Department of Physiology College of Medicine National Cheng Kung University Tainan Taiwan

5. Institute of Molecular Medicine College of Medicine National Cheng Kung University Tainan Taiwan

6. Department of Medical Research China Medical University Hospital China Medical University Taichung Taiwan

Funder

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13793

Reference81 articles.

1. The Fibroblast Growth Factor signaling pathway

2. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice

3. FGF13regulates proliferation and differentiation of skeletal muscle by down-regulatingSpry1

4. The Roles of Growth Factors in Keratinocyte Migration

5. Targeting FGFR Signaling in Cancer

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation;Acta Pharmacologica Sinica;2024-06-13

2. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist;Cells;2024-02-07

3. Liposome Nanoparticles Loaded with Paeoniflorin Protect Neuronal Damage in Parkinson’s Disease by Regulating miR-135a;Journal of Biomedical Nanotechnology;2024-02-01

4. FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist;2023-12-02

5. A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma;Molecular Therapy - Nucleic Acids;2023-12